Anika Therapeutics Stock Price and Value Analysis

Should you buy Anika Therapeutics stock? (NasdaqGS:ANIK). Let's see how it does in our automated value investing analysis system.

ANIK Free Cash Flow Trend

Free Cash Flow trendline for ANIK
Free Cash Flow trendline for Anika Therapeutics

Based on historical returns, we believe that Anika Therapeutics can grow its free cash at a rate of about 2%. That's positive!

  • This company is making money at a modest rate.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the ANIK Numbers

ANIK Price
(Anika Therapeutics stock price per share)
ANIK Fair Price
(based on intrinsic value)
ANIK Safety Price (based on a variable margin of safety) $21.29
PE Ratio versus Sector 35% higher than other Healthcare stocks
PE Ratio versus Industry 52% lower than other Biotechnology stocks
Cash Yield 5.05%
Free Cash Flow Jitter 41%

Is Anika Therapeutics Stock on Sale?

We believe that Anika Therapeutics may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Anika Therapeutics looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy ANIK Stock?

Does Anika Therapeutics have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.